Berlin, June 26, 2019 – Bayer will present new data highlighting the long-term clinical benefit and the positive impact on quality of life of Jivi® (BAY 94-9027) during The International Society on Thrombosis and Haemostasis (ISTH) Congress 2019, from 6 – 10 July 2019 in Melbourne, Australia.